Mr Philipp Haas > Niederer Kraft Frey AG > Zurich, Switzerland > Lawyer Profile

With demonstrable strengths across the pharmaceutical, financial services, and transport sectors, Niederer Kraft Frey AG also excels across the full gamut of capital markets transactions, including domestic securitisation and covered bond transactions, rights offerings, and public takeovers. The team is recommended for its ‘in-depth expertise’ and ‘excellent co-operation’. Philippe Weber harnesses his expertise in equity and debt capital market transactions to assist an array of issuers and other investors, while Daniel Bono enjoys extensive experience in handling issuance mandates. Thomas Brönnimann is highly experienced in advising issuers and investment banks in relation to IPOs, convertible bonds and block trades, and Philipp Haas strengthens the practice with his equity and convertible debt transactions, alongside market conduct rules.

Niederer Kraft Frey AG assists clients with the full range of corporate and regulatory matters, acting for diagnostics, medtech, and biotech corporations. Promoted to partner in January 2024, ‘outstanding lawyer and attorney’ Janine Reudt-Demont co-leads the team and is recommended for her deep regulatory knowledge, particularly in relation to advertising and data protection within the pharma and medical device industries. Co-head Philipp Haas is well-equipped to assist with public M&A and takeovers.

Noted for its ‘meticulous attention to detail, comprehensive industry knowledge, and proactive approach to legal strategy’, Niederer Kraft Frey AG is highly regarded for its cross-border capabilities and is particularly active in the sectors of pharmaceuticals, technology, and education, regularly being engaged to handle a diverse range of corporate and commercial matters. Three key players lead the firm’s offering: Patrik Peyer, who is well-positioned to advise clients on private equity M&A transactions and corporate law mandates, Philippe Weber, who represents a panoply of clients in relation to cross-border M&A and capital markets transactions, and Karim Piguet, a technology expert who is highly capable in the private equity and venture capital sphere. Philipp Haas boasts a varied practice that spans the sectors of pharmaceuticals, technology, and logistics, while Thomas Brönnimann is a strong choice for strategic and financial buyers and sellers operating in this space. Philip Spoerlé‘s capabilities encompass leveraged acquisition financings and public and private M&A, as well as capital markets transactions, and Moritz Maurer is also recommended.